Skip to main content
Merck's Be Well Logo
  • Worldwide  
  • Contact Us
  • Click this icon to learn more about Merck’s commitment to disability inclusion for employees, customers, external partners, and suppliers.
  • ABOUT US
    • About Us
    • Corporate Responsibility
    • Leadership
      • Board of Directors
      • Executive Committee
    • Our Work
      • Antimicrobial Resistance
      • Diabetes
      • HIV
      • Oncology
      • Vaccines
    • Perspectives
    • How We Operate
      • Code of Conduct
      • Compliance
      • Privacy
        • Transparency and Privacy
        • Internet Privacy Policy
        • Cookie Privacy Commitment
        • Cross Border Policy
        • Employment Privacy & Data Protection
      • Diversity
        • Employee Diversity
        • Programs and Partnerships
        • Supplier Diversity
    • Views and Positions
      • Access and Affordability
      • Access to Investigational Medicines
      • Innovation
      • Quality and Safety
      • Sales and Marketing
      • Responsible Public Policy and Advocacy
    • Our History
    • Our People
    • Featured Stories
  • Inventing For Life
    • Inventing For Life
  • PRODUCTS
    • Products
    • Product List A-Z
    • Vaccines & Prescribing Information
    • Prescription Products & Prescribing Information
    • Oncology Products & Prescribing Information
    • Animal Health
    • Access and Patient Assistance
    • Product Patents
    • Authorized Distributors
    • Safety Data Sheets (SDS)
  • RESEARCH
    • Research
    • Our People, Our Culture
      • The MRL Postdoctoral Fellow Program
    • Our R&D Process
    • What We're Working On
    • Pipeline
    • Clinical Trials
    • Invent with Us
    • Discover Where Our Research Happens
  • LICENSING
    • Business Development & Licensing
    • BD&L Contacts
    • News & Events
  • NEWSROOM
    • Newsroom
    • News Releases
      • Prescription Medicine News
      • Consumer Care News
      • Vaccine News
      • Research & Development News
      • Corporate News
      • Financial News
      • Corporate Responsibility News
      • Animal Health News
    • Information Centers
      • Diabetes
      • Ebola
      • Oncology
    • Company Statements
    • Media Center
    • Company Snapshot
    • Social Media
  • CAREERS
    • Careers
    • Search Jobs
    • Our Divisions
      • Research & Development
      • Manufacturing & Supply
      • Human Health
      • Animal Health
      • Global Support Functions
    • Diversity & Inclusion
    • Compensation & Benefits
    • Veterans
    • Student Opportunities
    • How We Hire
    • MSD Careers
    • Talent Community
    • Events
  • INVESTORS
    • Investors
    • Product Pipeline
    • News
    • Events & Presentations
    • Stock Info
      • Stock Quote & Chart
      • Historical Price Look-up
      • Investment Calculator
      • Dividend History
      • Stock Splits
      • Analyst Coverage
    • Financials
      • Quarterly Reports
      • Annual Reports & Proxy
      • SEC Filings
    • Governance
    • Investor Resources
      • FAQs
      • Stockholder Services
      • Corporate Responsibility
      • Information Request
      • Sign up for Email Alerts
      • Other
      • Contact Us
Menu
Home/ Investors/Governance
Share
  • About Us
    • Corporate Responsibility
    • Reimbursement Support and Patient Assistance Programs
    • Leadership
      • Board of Directors
      • Executive Committee
    • Our Work
    • How We Operate
      • Code of Conduct
      • Compliance
      • Privacy
        • Transparency and Privacy
        • Internet Privacy Policy
        • Cookie Privacy Commitment
        • Cross Border Policy
        • Employment Privacy & Data Protection
      • Diversity
        • Employee Diversity
        • Programs and Partnerships
        • Supplier Diversity
    • Views and Positions
      • Access and Affordability
      • Access to Investigational Medicines
      • Innovation
      • Quality and Safety
      • Sales and Marketing
      • Responsible Public Policy and Advocacy
    • Our History
    • Our People
    • Featured Stories
  • Inventing for Life
  • Research
    • Our People, Our Culture
      • – The MRL Postdoctoral Fellow Program
    • Our R&D Process
    • What We're Working On
    • Pipeline
    • Clinical Trials
    • Invent with Us
    • Discover Where Our Research Happens
  • Products
    • Product List A-Z
    • Vaccines & Prescribing Information
    • Prescription Products & Prescribing Information
    • Oncology Products & Prescribing Information
    • Animal Health
    • Access and Patient Assistance
    • Product Patents
    • Authorized Distributors
    • Safety Data Sheets (SDS)
  • Careers
    • Search Jobs
    • Our Divisions
      • Research & Development
      • Manufacturing & Supply
      • Human Health
      • Animal Health
      • Global Support Functions
    • Diversity & Inclusion
    • Veterans
    • Student Opportunities
    • Compensation & Benefits
    • How We Hire
    • MSD Careers
    • Events
    • Talent Community
  • Investors
  • Newsroom
    • News Releases
      • Prescription Medicine News
      • Consumer Care News
      • Vaccine News
      • Research & Development News
      • Corporate News
      • Financial News
      • Corporate Responsibility News
      • Animal Health News
    • News Releases
      • Diabetes
      • Ebola
      • Oncology
    • Company Statements
    • Media Center
    • Company Snapshot
    • Social Media
  • Licensing
    • BD&L Contacts
    • News & Events
  • Contact Us
    • FAQ
  • IR Home
  • Product Pipeline
  • News
  • Events & Presentations
  • Stock Info
    • Stock Quote & Chart
    • Historical Price Look-up
    • Investment Calculator
    • Dividend History
    • Stock Splits
    • Analyst Coverage
  • Financials
    • Quarterly Reports
    • Annual Reports & Proxy
    • SEC Filings
  • Governance
    • Leadership & Governance
    • Executive Committee
    • Board of Directors
    • Annual Reports & Proxy
  • Investor Resources
    • FAQs
    • Stockholder Services
    • Corporate Responsibility
    • Information Request
    • Sign up for Email Alerts
    • Other
    • Contact Us
  • IR Home
  • Product Pipeline
  • News
  • Events & Presentations
  • Stock Info
    • Stock Quote & Chart
    • Historical Price Look-up
    • Investment Calculator
    • Dividend History
    • Stock Splits
    • Analyst Coverage
  • Financials
    • Quarterly Reports
    • Annual Reports & Proxy
    • SEC Filings
  • Governance
    • Leadership & Governance
    • Executive Committee
    • Board of Directors
    • Annual Reports & Proxy
  • Investor Resources
    • FAQs
    • Stockholder Services
    • Corporate Responsibility
    • Information Request
    • Sign up for Email Alerts
    • Other
    • Contact Us
Home/ Investors  >  Governance
  • Leadership & Governance
  • Executive Committee
  • Board of Directors
  • Annual Reports & Proxy

Corporate governance structures are established to make sure corporations are accountable to their owners—the shareholders.

Our corporate governance goes beyond the company's relationship to our shareholders, because it reflects our relationship to society, and issues that matter to our key stakeholders can very quickly become important issues for our shareholders. As such, our objective is to balance fiduciary duty and accountability to generate long-term shareholder value, while also considering, in a transparent manner, the concerns of other stakeholders.

More information on Corporate Governance at Merck.

Download year list
Download
Policies of the Board (opens in new window)
Certificate of Incorporation (opens in new window) 242 KB
By-Laws (opens in new window) 238 KB

Investor Contact

Monday - Friday, 8:30 a.m - 4:00 p.m., ET

908 740-1 INV (908 740-1468)

investor_relations@merck.com

Email Alerts

*
*




 
Enter the code shown above.

Copyright © 2009- Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. All rights reserved.
  • Forward-Looking Statement
  • Privacy
  • Cookie Settings
  • Terms of Use
  • Site Map

Forward-Looking Statement

Forward-Looking Statement of Merck & Co., Inc., Kenilworth, NJ, USA

This news release of Merck & Co., Inc., Kenilworth, N.J., USA (the “company”) includes “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of the recent global outbreak of novel coronavirus disease (COVID-19); the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.

The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in the company’s 2019 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).

No Duty to Update

The information contained in this website was current as of the date presented. The company assumes no duty to update the information to reflect subsequent developments. Consequently, the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date.

TRUSTe
TRUSTe
Powered By Q4 Inc. 5.91.0.8 (opens in new window)